Home News & Events Events Workshops Workshops Page tools Share Share Share on LinkedinShare on BlueskyShare on XShare on Facebook Print Search Email Accessibility Workshop NONMEM Introduction Workshop (China Region): Applications in PK/PD Modeling (Mandarin Language) Date 31 July 2026 Time 09:00 - 12:00 Location Online/Virtual Webex Timezone Asia/Shanghai Workshop NONMEM Introduction Workshop (China Region): Applications in PK/PD Modeling (Mandarin Language) Date 3 September 2026 Time 09:00 - 12:00 Location Online/Virtual Webex Timezone Asia/Shanghai Workshop Beginners/Intermediate Online NONMEM/PDx-Pop Workshop Date 22 September 2026 - 23 September 2026 Time 09:00 - 17:00 Location Online/Virtual Webex Timezone America/New York Workshop Advanced Online NONMEM/PDx-Pop Workshop Date 24 September 2026 Time 09:00 - 17:00 Location Online/Virtual Webex Timezone America/New York Workshop New and Advanced Features of NONMEM 7.6 at ACoP 2026 In Person Workshop Date 10 October 2026 Time 08:00 - 17:00 Location Gaylord National Resort & Convention Center, Oxon Hill, Maryland, USA. Timezone America/New York In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events ASCO 2026 Webinars Workshops Webinars Social media hub Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Event Webinars Event Industry Events What’s happening in ICON ICON Plc Real-time clinical trials are moving from concept to reality, led by the FDA’s latest initiative to enable near real-time data sharing and AI-enabled decision-making. But what does this mean in a global regulatory landsc... 19h View post View webpage ICON Plc Critical care trials push the limits, with tight timelines, shifting patient status, and consent challenges that don’t fit traditional models. Success depends on protocols that reflect real ICU dynamics, operations that ... 20h View post View webpage ICON Plc ICON Laboratories now offers comprehensive blood-based biomarker testing for Alzheimer’s disease and neurodegenerative disorders—supporting earlier detection, improved patient access, and smarter clinical development str... 21h View post View webpage ICON Plc Combination products sit at the intersection of drug and device innovation. As a result, regulatory pathways remain complex and evolving. In Pharma Focus Asia, ICON’s Global Head of Regulatory CMC, Venkat Sunkara, MSc, ... 22h View post View webpage ICON Plc Since 2024, new guidance from the FDA and EMA has advanced efforts to streamline biosimilar development to enhance commercial appeal for developers. Explore the implications of new regulatory guidance and publications,... 17 Jun View post View webpage ICON Plc We’re proud to be sponsoring the SOLAR conference taking place on June 25-27. Our hepatology team will be there and looking forward to connecting with others working to advance liver disease research, especially across ... 16 Jun View post View webpage ICON Plc Osivelotor is an oral investigational drug for the treatment of sickle cell disease (SCD) designed to inhibit hemoglobin polymerization. In a phase 1, open-label ADME study conducted in healthy participants at ICON’s cli... 16 Jun View post View webpage ICON Plc Attending DIA in Philadelphia? Stop by Booth \#1426 to meet the ICON team and explore ICON’s solutions to improve speed, quality and efficiency across clinical development, from AI-enabled trial delivery to regulatory st... 15 Jun View post ICON Plc ICON Biotech will be onsite at CTO East Coast, taking place 30 June – 1 July at the Boston Marriott Burlington, MA. As a leading provider of integrated clinical research services, ICON supports oncology and biotech compa... 15 Jun View post View webpage ICON Plc Latest issue out now. Do you struggle to keep on top of regulatory changes affecting the world of medicine and medical device clinical trials? Join thousands of subscribers who have discovered the convenience of our fr... 15 Jun View post View webpage ICON Plc Visit us at DIA Philadelphia, 14–18 June, Booth \#1426, and explore ICON’s solutions spanning AI-driven trials, regulatory strategy, faster start-up and high-performing site models. https://ow.ly/1VF950Z29B7 12 Jun View post View webpage ICON Plc We’re pleased to be part of ACRO’s Good Clinical Podcast focused on advancing rare disease research through AI innovation and patient trust. In the discussion, ICON’s Tanya Binette highlights where AI is delivering valu... 12 Jun View post View webpage
